ReviewCancers2021

Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC).

Rosa Wijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.